237 related articles for article (PubMed ID: 29385688)
1. Small Molecules in Rare Tumors: Emerging Role of MicroRNAs in GIST.
Kupcinskas J
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385688
[TBL] [Abstract][Full Text] [Related]
2. A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors.
Isosaka M; Niinuma T; Nojima M; Kai M; Yamamoto E; Maruyama R; Nobuoka T; Nishida T; Kanda T; Taguchi T; Hasegawa T; Tokino T; Hirata K; Suzuki H; Shinomura Y
PLoS One; 2015; 10(7):e0133754. PubMed ID: 26214687
[TBL] [Abstract][Full Text] [Related]
3. The Role of miR-375-3p and miR-200b-3p in Gastrointestinal Stromal Tumors.
Gyvyte U; Lukosevicius R; Inciuraite R; Streleckiene G; Gudoityte G; Bekampyte J; Valentini S; Salteniene V; Ruzgys P; Satkauskas S; Zviniene K; Kupcinskas J; Skieceviciene J
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708220
[TBL] [Abstract][Full Text] [Related]
4. Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors.
Yun S; Kim WK; Kwon Y; Jang M; Bauer S; Kim H
Int J Cancer; 2018 May; 142(10):2080-2093. PubMed ID: 29277888
[TBL] [Abstract][Full Text] [Related]
5. PIK3C2A is a gene-specific target of microRNA-518a-5p in imatinib mesylate-resistant gastrointestinal stromal tumor.
Shi Y; Gao X; Hu Q; Li X; Xu J; Lu S; Liu Y; Xu C; Jiang D; Lin J; Xue A; Tan Y; Shen K; Hou Y
Lab Invest; 2016 Jun; 96(6):652-60. PubMed ID: 26950487
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.
Kim WK; Park M; Kim YK; Tae YK; Yang HK; Lee JM; Kim H
Clin Cancer Res; 2011 Dec; 17(24):7584-94. PubMed ID: 22042971
[TBL] [Abstract][Full Text] [Related]
7. Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST].
Kelly L; Bryan K; Kim SY; Janeway KA; Killian JK; Schildhaus HU; Miettinen M; Helman L; Meltzer PS; van de Rijn M; Debiec-Rychter M; O'Sullivan M;
PLoS One; 2013; 8(5):e64102. PubMed ID: 23717541
[TBL] [Abstract][Full Text] [Related]
8. Expression profile of microRNAs in gastrointestinal stromal tumors revealed by high throughput quantitative RT-PCR microarray.
Tong HX; Zhou YH; Hou YY; Zhang Y; Huang Y; Xie B; Wang JY; Jiang Q; He JY; Shao YB; Han WM; Tan RY; Zhu J; Lu WQ
World J Gastroenterol; 2015 May; 21(19):5843-55. PubMed ID: 26019448
[TBL] [Abstract][Full Text] [Related]
9. Identification of long intergenic non-coding RNAs (lincRNAs) deregulated in gastrointestinal stromal tumors (GISTs).
Gyvyte U; Kupcinskas J; Juzenas S; Inciuraite R; Poskiene L; Salteniene V; Link A; Fassan M; Franke A; Kupcinskas L; Skieceviciene J
PLoS One; 2018; 13(12):e0209342. PubMed ID: 30557328
[TBL] [Abstract][Full Text] [Related]
10. Fascin-1 overexpression and miR-133b downregulation in the progression of gastrointestinal stromal tumor.
Yamamoto H; Kohashi K; Fujita A; Oda Y
Mod Pathol; 2013 Apr; 26(4):563-71. PubMed ID: 23196799
[TBL] [Abstract][Full Text] [Related]
11. [Screening of differentially expressed microRNAs in borderline and malignant gastrointestinal stromal tumors].
Shi Y; Wang CZ; Hou YY; He DM; Xu C; Liu YL; Hu Q; Akesu S; Zeng HY; Shen KT; Tan YS; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):20-5. PubMed ID: 23611268
[TBL] [Abstract][Full Text] [Related]
12. miRNAs expression pattern and machine learning models elucidate risk for gastric GIST.
Stefanou IK; Dovrolis N; Gazouli M; Theodorou D; Zografos GK; Toutouzas KG
Cancer Biomark; 2022; 33(2):237-247. PubMed ID: 35213356
[TBL] [Abstract][Full Text] [Related]
13. Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site.
Antonescu CR; Viale A; Sarran L; Tschernyavsky SJ; Gonen M; Segal NH; Maki RG; Socci ND; DeMatteo RP; Besmer P
Clin Cancer Res; 2004 May; 10(10):3282-90. PubMed ID: 15161681
[TBL] [Abstract][Full Text] [Related]
14. MiR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor.
Liu S; Cui J; Liao G; Zhang Y; Ye K; Lu T; Qi J; Wan G
Tumour Biol; 2014 Sep; 35(9):9131-8. PubMed ID: 25027394
[TBL] [Abstract][Full Text] [Related]
15. Non-Coding RNAs, a Novel Paradigm for the Management of Gastrointestinal Stromal Tumors.
Amirnasr A; Sleijfer S; Wiemer EAC
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32972022
[TBL] [Abstract][Full Text] [Related]
16. Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31.
Haller F; von Heydebreck A; Zhang JD; Gunawan B; Langer C; Ramadori G; Wiemann S; Sahin O
J Pathol; 2010 Jan; 220(1):71-86. PubMed ID: 19768731
[TBL] [Abstract][Full Text] [Related]
17. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.
Miettinen M; Majidi M; Lasota J
Eur J Cancer; 2002 Sep; 38 Suppl 5():S39-51. PubMed ID: 12528772
[TBL] [Abstract][Full Text] [Related]
18. An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).
Nannini M; Biasco G; Astolfi A; Pantaleo MA
J Med Genet; 2013 Oct; 50(10):653-61. PubMed ID: 23833252
[TBL] [Abstract][Full Text] [Related]
19. PCAT6 mediates cellular biological functions in gastrointestinal stromal tumor via upregulation of PRDX5 and activation of Wnt pathway.
Bai F; Zhang N; Fang W; He X; Zheng Y; Gu D
Mol Carcinog; 2020 Jun; 59(6):661-669. PubMed ID: 32339330
[TBL] [Abstract][Full Text] [Related]
20. Serum miR-518e-5p is a potential biomarker for secondary imatinib-resistant gastrointestinal stromal tumor.
Kou Y; Yang R; Wang Q
J Biosci; 2018 Dec; 43(5):1015-1023. PubMed ID: 30541960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]